Literature DB >> 20093396

Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice.

Fernanda B M Priviero1, Li-Ming Jin, Zhekang Ying, Cleber E Teixeira, R Clinton Webb.   

Abstract

We tested the hypothesis that the basal release of nitric oxide (NO) from endothelial cells modulates contractile activity in the corpus cavernosum (CC) via inhibition of the RhoA/Rho-kinase signaling pathway. Cavernosal strips from wild-type (WT), endothelial nitric-oxide synthase knockout [eNOS(-/-)], and neuronal nitric-oxide synthase knockout [nNOS(-/-)] mice were mounted in myographs, and isometric force was recorded. mRNA and protein expression of key molecules in the RhoA/Rho-kinase pathway were analyzed by real-time polymerase chain reaction and Western blot, respectively. The cGMP levels were determined. The Rho-kinase inhibitors (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide (Y-27632) and (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl] homopiperazine (H-1152) reduced cavernosal contractions evoked by phenylephrine or electrical field stimulation (EFS) in a concentration-dependent manner, although this inhibition was less effective in tissues from eNOS(-/-) mice. Y-27632 enhanced relaxations induced by sodium nitroprusside, EFS, and NO (administered as acidified NaNO2) without affecting the cGMP content of the cavernosal strips. This enhancement was less prominent in CC from eNOS(-/-). The protein expression of RhoA, Rho-guanine dissociation inhibitor, and Rho-kinase beta did not differ among the strains. However, in eNOS(-/-) CC, the protein expression of Rho-kinase alpha and both mRNA and protein expression of p115-Rho-associated guanine exchange factor (RhoGEF), PDZ-RhoGEF, and leukemia-associated RhoGEF were up-regulated. Phosphorylation of MYPT1 at Thr696 was higher in tissues from eNOS(-/-) mice. A high concentration of Y-27632 significantly enhanced NO release in CC stimulated by EFS. These results suggest a basal release of NO from endothelial cells, which inhibits contractions mediated by the RhoA/Rho-kinase pathway and modulates the expression of proteins related to this pathway in mouse CC. It indicates that endothelial integrity is essential to the maintenance of erectile function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093396      PMCID: PMC2846021          DOI: 10.1124/jpet.109.160606

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  32 in total

Review 1.  Smooth muscle contraction and relaxation.

Authors:  R Clinton Webb
Journal:  Adv Physiol Educ       Date:  2003-12       Impact factor: 2.288

Review 2.  Physiology of penile erection and pathophysiology of erectile dysfunction.

Authors:  Robert C Dean; Tom F Lue
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

3.  Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase.

Authors:  Shaohua Chang; Joseph A Hypolite; Stephen A Zderic; Alan J Wein; Samuel Chacko; Michael E Disanto
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-06-16       Impact factor: 3.619

4.  Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation.

Authors:  E F Etter; M Eto; R L Wardle; D L Brautigan; R A Murphy
Journal:  J Biol Chem       Date:  2001-07-18       Impact factor: 5.157

5.  Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.

Authors:  Cleber E Teixeira; Liming Jin; Zhekang Ying; Trenis Palmer; Fernanda B M Priviero; R Clinton Webb
Journal:  Clin Exp Pharmacol Physiol       Date:  2005-10       Impact factor: 2.557

6.  Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.

Authors:  K Chitaley; C J Wingard; R Clinton Webb; H Branam; V S Stopper; R W Lewis; T M Mills
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

7.  Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum.

Authors:  R W Rees; D J Ralph; M Royle; S Moncada; S Cellek
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

8.  Proerectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the rat penis.

Authors:  Cleber E Teixeira; Zhekang Ying; R Clinton Webb
Journal:  J Pharmacol Exp Ther       Date:  2005-06-23       Impact factor: 4.030

9.  cGMP-dependent protein kinase phosphorylates and inactivates RhoA.

Authors:  N Sawada; H Itoh; J Yamashita; K Doi; M Inoue; K Masatsugu; Y Fukunaga; S Sakaguchi; M Sone; K Yamahara ; T Yurugi; K Nakao
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

10.  Nitrergic-noradrenergic interaction in penile erection: a new insight into erectile dysfunction.

Authors:  S Cellek
Journal:  Drugs Today (Barc)       Date:  2000 Feb-Mar       Impact factor: 2.245

View more
  12 in total

1.  Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1.

Authors:  Fernanda R Giachini; Victor V Lima; Fernando S Carneiro; Rita C Tostes; R Clinton Webb
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

Review 2.  Understanding and targeting the Rho kinase pathway in erectile dysfunction.

Authors:  Nikolai A Sopko; Johanna L Hannan; Trinity J Bivalacqua
Journal:  Nat Rev Urol       Date:  2014-10-14       Impact factor: 14.432

3.  Inhibition of Rho-kinase improves erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injury.

Authors:  Johanna L Hannan; Maarten Albersen; Omer Kutlu; Christian Gratzke; Christian G Stief; Arthur L Burnett; Jeffrey J Lysiak; Petter Hedlund; Trinity J Bivalacqua
Journal:  J Urol       Date:  2012-09-25       Impact factor: 7.450

4.  The influence of ethanol intake on RhoA/Rho kinase signaling pathway in corpus cavernosum of OLETF rats.

Authors:  Su Jin Kim; Woong Jin Bae; Jin Hee Han; Sung Hoo Hong; Sae Woong Kim; Tae-Kon Hwang; Dai Jin Kim; Ji Youl Lee
Journal:  Int Urol Nephrol       Date:  2013-01-05       Impact factor: 2.370

Review 5.  NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism.

Authors:  Bernardo Moreno-López; Carmen R Sunico; David González-Forero
Journal:  Mol Neurobiol       Date:  2010-12-29       Impact factor: 5.590

6.  Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.

Authors:  Haroldo A Toque; Kenia P Nunes; Lin Yao; James K Liao; R Clinton Webb; Ruth B Caldwell; R William Caldwell
Journal:  J Sex Med       Date:  2013-04-08       Impact factor: 3.802

7.  Macrophage-Specific Toll Like Receptor 9 (TLR9) Causes Corpus Cavernosum Dysfunction in Mice Fed a High Fat Diet.

Authors:  Fernanda Priviero; Fabiano Calmasini; Vanessa Dela Justina; Camilla F Wenceslau; Cameron G McCarthy; R Clinton Webb
Journal:  J Sex Med       Date:  2021-03-16       Impact factor: 3.802

8.  Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia.

Authors:  Mário Angelo Claudino; Kleber Yotsumoto Fertrin
Journal:  Anemia       Date:  2012-06-13

9.  Smooth muscle specific Rac1 deficiency induces hypertension by preventing p116RIP3-dependent RhoA inhibition.

Authors:  Gwennan André; Juan E Sandoval; Kevin Retailleau; Laurent Loufrani; Gilles Toumaniantz; Stefan Offermanns; Malvyne Rolli-Derkinderen; Gervaise Loirand; Vincent Sauzeau
Journal:  J Am Heart Assoc       Date:  2014-06-17       Impact factor: 5.501

10.  Impaired Corpus Cavernosum Relaxation Is Accompanied by Increased Oxidative Stress and Up-Regulation of the Rho-Kinase Pathway in Diabetic (Db/Db) Mice.

Authors:  Fernanda B M Priviero; Haroldo A F Toque; Kenia Pedrosa Nunes; Denise G Priolli; Cleber E Teixeira; R Clinton Webb
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.